Sunday feature: The Australian biotech on the verge of a major breakthrough

Guest: Mesoblast founder Silviu Itescu

Original air date: March 9, 2022

ASX-listed biotech Mesoblast is spoken about a lot on Fear and Greed due to its extremely volatile share price. This is largely tied to some big medical breakthroughs they've been working on for a long time.

Founder Silviu Itescu discusses the exhaustive and expensive process behind getting critical new drugs developed, tested and approved and the possible announcements that are coming.

Update: Mesoblast has been in the news this week. Its share price shot up due to investor excitement over its pending Food & Drug Administration submission.

Find out more: https://fearandgreed.com.au/

See omnystudio.com/listener for privacy information.